✦ LIBER ✦

Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor

✍ Scribed by Hsu, Jerry Y.; Wakelee, Heather A.

Book ID: 121352401
Publisher: Springer International Publishing AG
Year: 2009
Tongue: English
Weight: 323 KB
Volume: 23
Category: Article
ISSN: 1173-8804
DOI: 10.2165/11317600-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tanibirumab (TTAC-0001): A fully human m

Tanibirumab (TTAC-0001): A fully human monoclonal antibody targets vascular endothelial growth factor receptor 2 (VEGFR-2)

✍ Sang Hoon Lee 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 701 KB

Targeting vascular endothelial growth fa

Targeting vascular endothelial growth factor with the monoclonal antibody bevacizumab inhibits human hepatocellular carcinoma cells growing in an orthotopic mouse model

✍ Richard S. Finn; Greg Bentley; Carolyn D. Britten; Rafael Amado; Ronald W. Busut 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 728 KB

Targeting Vascular Endothelial Growth Fa

Targeting Vascular Endothelial Growth Factor (VEGF) for Anti-tumor Therapy, by Anti-VEGF Neutralizing Monoclonal Antibodies or by VEGF Receptor Tyrosine-kinase Inhibitors

✍ Jean-Marc Schlaeppi; Jeanette M. Wood 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 53 KB

Targeting Vascular Endothelial Growth Fa

Targeting Vascular Endothelial Growth Factor

✍ Dr Michael Waisbourd, Anat Loewenstein, Michaella Goldstein… 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 266 KB

Generation of Monoclonal Antibodies to R

Generation of Monoclonal Antibodies to Recombinant Vascular Endothelial Growth Factor

✍ S. A. Shein, O. I. Gurina, A. V. Leopol’d, V. P. Baklaushev, A. A. Korchagina, N 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 600 KB

Tumor-targeting properties of antibody–v

Tumor-targeting properties of antibody–vascular endothelial growth factor fusion proteins

✍ Cornelia Halin; Uwe Niesner; Maria Elena Villani; Luciano Zardi; Dario Neri 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 293 KB

## Abstract A major problem of antibody‐based targeting of solid tumors is the poor penetration of antibodies into tumor tissue. Vasoactive immunoconjugates have been proposed as a means of increasing antibody uptake in tumors. In principle, VEGF (also known as vascular permeability factor) could s